l-carnitine and prostate cancer Supplementation in Patients with Advanced Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study Acetyl-l-carnitine is an anti-angiogenic agent
Description
If you notice any unusual symptoms, it is best to discontinue use and consult a professional
R.AnandamR.KasthuriJ
Funding This work was supported by the National Natural Science Foundation of China (32002184 to BW), the ZhiYuan project of Inner Mongolia Medical University (ZY0120025 to LS), and the Key Technology Research, Development and Transformation Projects of Inner Mongolia (2021GG0402 to YD and 2022YFSH0102 to YM)
3.Metabolic disorder: inappetence, Lactation reduction, stress, frailty
Reported mechanistic emphasis includes NO/angiogenesis signaling + cell migration/repair pathways
